IO Biotech: Funding, Investors & Team (Sep 2026)
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. The pipeline of first-in-class immune modulating anti-cancer therapies is developed by a unique technology platform, T-win®, enabling the activation of T cells that are specific for immune-suppressive molecules. IO Biotech has a proven track record of progressing preclinical and clinical compounds. The two lead compounds targeting IDO and PD-L1 are in clinical development and several pipeline compounds are in pre-clinical phase.
IO Biotech has raised $59.6M across 2 funding rounds on record, the most recent an undisclosed round of $59.6M announced in Dec 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
IO Biotech Company Profile and Key Stats
Latest funding round on record: Dec 2024.
IO Biotech Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
IO Biotech announced an undisclosed round in Aug 2023; the amount was not disclosed.
1.3 years later, an undisclosed round of $59.6M was announced in Dec 2024.
IO Biotech Founders and Leadership Team
No contact details are on record for this team yet.
IO Biotech Funding Compared to Other Biotechnology Startups
IO Biotech's latest round of $59.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like IO Biotech in Biotechnology and Copenhagen
Companies Similar to IO Biotech
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
IO Biotech Funding FAQs
What does IO Biotech do?
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. The pipeline of first-in-class immune modulating anti-cancer therapies is developed by a unique technology platform, T-win®, enabling the activation of T cells that are specific for immune-suppressive molecules. IO Biotech has a proven track record of progressing preclinical and clinical compounds. The two lead compounds targeting IDO and PD-L1 are in clinical development and several pipeline compounds are in pre-clinical phase.
How much funding has IO Biotech raised?
IO Biotech has raised $59.6M across 2 rounds on record. The most recent is an undisclosed round of $59.6M announced in Dec 2024.
When did IO Biotech last raise funding?
IO Biotech's most recent funding round on record is an undisclosed round of $59.6M, announced in Dec 2024.
Who founded IO Biotech?
FundedIQ lists Anders Ljungqvist (Founder), Inge Svane (Founder) at IO Biotech.
Where is IO Biotech headquartered?
IO Biotech is based in Copenhagen, Hovedstaden, Denmark.
How many employees does IO Biotech have?
IO Biotech is in the 51-100 employee band.
How does IO Biotech's funding compare to other Biotechnology startups?
IO Biotech's latest round of $59.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's IO Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IO Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.